Trends in Kaposi’s Sarcoma Morbidity: A Retrospective Cohort Study of Heart and Lung Transplant Recipients
DOI:
https://doi.org/10.2340/00015555-3899Keywords:
Kaposi’s sarcoma, heart transplant recipients, lung transplant recipients, immunosuppressive maintenance therapy, mammalian target of rapamycin inhibitors, epidemiologyAbstract
Data on post-transplant Kaposi’s sarcoma in heart and lung transplant recipients are sparse. This study examined the incidence of biopsy-proven post-transplant Kaposi’s sarcoma in thoracic organ recipients over a period of 20 years. As mammalian target of rapamycin inhibitors were introduced in 2006 as optional maintenance immunosuppressive therapy, the overall results were analysed and stratified into 2 groups: 1996 to 2005 and 2006 to 2016. A total of 867 transplant recipients met the study criteria. Post-transplant Kaposi’s sarcoma was diagnosed in 7 (0.81%) patients. Five cases (0.19% of transplant recipients) were recorded in 1996 to 2005 and 2 (0.03% of transplant recipients) in 2006 to 2016 (p = 0.04). Multivariable logistic regression analyses identified the following as risk factors: period of transplantation (odds ratio (OR) 4.844, 95% confidence interval (95% CI) 1.156–20.291), age at transplantation (OR 1.066, 95% CI 0.992–1.145), and North African origin (OR 7.282, 95% CI 12.55–42.254). This study found a decreased incidence of post-transplant Kaposi’s sarcoma over the last 20 years, mainly attributed
Downloads
References
Braun M. Classics in oncology. Idiopathic multiple pigmented sarcoma of the skin by Kaposi. CA Cancer J Clin 1982; 32: 340–347.
MMWR (Weekly). Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men – New York City and California. MMWR Morb. Mortal Wkly Rep 1981; 30: 305–307.
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994; 266: 1865–1869.
Cook-Mozaffari P, Newton R, Beral V, Burkitt DP. The geographical distribution of Kaposi’s sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 1998; 78: 1521–1528 .
Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335: 123–128.
Penn I. Kaposi’s sarcoma in transplant recipients. Transplantation 1997; 64:669–673.
Qunibi W, Al-Furayh O, Almeshari K, Lin SF, Sun R, Heston L, et al. Serologic association of human herpesvirus eight with posttransplant Kaposi’s sarcoma in Saudi Arabia. Transplantation 1998; 65: 583–585.
Moosa MR. Racial and ethnic variations in incidence and pattern of malignancies after kidney transplantation. Medicine 2005; 84: 12–22.
Morath C, Mueller M, Goldschmidt H, Schwenger V, Opelz G, Zeier M. Malignancy in renal transplantation. J Am Soc Nephrol 2004; 15: 1582–1588.
Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1–17, 18–20.
Antman K, Chang Y. Kaposi’s sarcoma. N Engl J Med 2000; 342: 1027–1038.
Frances C, Marcelin AG, Legendre C, Chevret S , Dussaix E, Lejeune J, et. al. The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients and the skin and organ transplantation group of the French Society of Dermatology. Am J Transplant 2009; 9: 2580–2586.
Stallone G, Schena A, Infante B, Di Paolo S , Loverre A, Maggio G, et al. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 2005; 352: 1317–1323.
Geissler EK. Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer? Transplant Res 2015; 4: 1.
Davidovici B, Karakis I, Bourboulia D, Ariad S , Zong J , Benharroch D, et al. Seroepidemiology and molecular epidemiology of Kaposi’s sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst 2001; 93: 194–202.
Zahger D, Lotan C, Admond D, Klapholz L, Kaufman B, Shimon D, et al. Very early appearance of Kaposi’s sarcoma after cardiac transplantation in Sephardic Jews. Am Heart J 1993; 126: 999–1000.
Piselli P, Busnach G, Citterio F, Frigerio M, Arbustini E, Burra P, et al. Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4767 recipients in Italy, 1970–2006. Transplant Proc 2009; 41: 1227–1230.
Cahoon EK, Linet MS, Clarke CA, Pawlish KS, Engels EA, Pfeiffer RM. Risk of Kaposi sarcoma after solid organ transplantation in the United States. Int J Cancer 2018; 143: 2741–2748.
Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology 2000; 47: 119–125.
Ryffel B, Mihatsch MJ, Fisher GL. Immunosuppression and cancer: the ciclosporin case. Drug Chem Toxicol 1992; 15: 95–115.
Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905–913.
Mbulaiteye SM Engels EA. Kaposi’s sarcoma risk among transplant recipients in the United States (1993–2003). Int J Cancer 2006; 119: 2685–2691.
Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 2007; 21: 1387–1394.
Iscovich J, Boffetta P, Winkelmann R, Brennan P, Azizi E. Classic Kaposi’s sarcoma in Jews living in Israel, 1961–1989: a population-based incidence study. AIDS 1998; 12: 2067–2072.
Zurrida S, Bartoli S, Nole F, Agresti R. Classic Kaposi’s sarcoma: a review of 90 cases. J Dermatol 1992; 19: 548–552.
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
